H.R.4399: Support And Value Expectant Moms and Babies Act of 2019

Overview

H.R. 4399 would prevent the use of telemedicine or mail for medication abortion, prevent the Food and Drug Administration (FDA) from approving new medication abortion drugs, and prevent labeling changes for already approved drugs.

S. 3072 is the Senate companion bill introduced by Sen. Cindy Hyde-Smith.

Related Bills

H.R.117

The NEWBORN Act would fund a $10 million in an annual grant through HHS to support pilot programs that address infant mortality. Specifically, grants must be awarded to local and tribal health departments in areas with the highest rates of infant mortality to establish pilot programs that address specified issues, including birth defects, premature births, […]

View Bill

S.116

The MOMS Act (S. 116) would establish the Alliance for Innovation on Maternal Health program through HHS and allocate it $5 million annually through FY2024. This program would facilitate the implementation of standardized best-practices to prevent, identify, and appropriately respond to pregnancy-related complications and help reduce maternal mortality. The bill would also create a $40 […]

View Bill
Contact Your Members of Congress

Our Stance

Oppose

Priority

Medium

Bill Number

H.R.4399

Date Introduced

September 19, 2019

Committee

House Energy and Commerce Committee

Bill Status

Introduced or Prefiled

Sponsor

Rep. Robert E. Latta

Co Sponsors